BBLN:NYE-Babylon Holdings Ltd (USD)

COMMON STOCK | Health Information Services | NYE

Last Closing Price

USD 0.76

Change

0.00 (0.00)%

Market Cap

USD 0.32B

Volume

1.14M

Avg Analyst Target

USD 4.75 (+521.16%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

BBLN Stock Forecast & Price:
Based on the Babylon Holdings Ltd stock forecasts from 4 analysts, the average analyst target price for Babylon Holdings Ltd is USD 4.75 over the next 12 months. Babylon Holdings Ltd’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Babylon Holdings Ltd is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Babylon Holdings Ltd’s stock price was USD 0.76. Babylon Holdings Ltd’s stock price has changed by -24.29% over the past week, -21.53% over the past month and 0% over the last year.

About Babylon Holdings Ltd (BBLN:NYE)

Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in ...Read More

Company Website : https://www.babylonhealth.com

Address : 1 Knightsbridge Green, London, United Kingdom, SW1X 7QA

Employees : 2,573

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

52 Week High : 16.00

Short Ratio : 5.69

52 Week Low : 0.72

Shorted Shares : 2,773,520

200 Day Moving Average : 4.12

Shorted Shares Previous Month : 2,557,783

50 Day Moving Average : 1.05

Shares Held By Insiders : 45.97%

Short Percentage : 2.35%

Shares Held by Institutions : 32.80%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-14 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VEEV Veeva Systems Inc Class A

N/A

 USD34.90B 89.08 60.09
DOCS Doximity Inc

N/A

 USD7.27B 54.26 59.71
TDOC Teladoc Inc

N/A

 USD6.52B N/A -0.71
EVH Evolent Health Inc

N/A

 USD3.20B N/A 58.37
AGTI Agiliti Inc

N/A

 USD2.24B 69.92 11.53
AMWL American Well Corp

N/A

 USD1.41B N/A -3.59
PHR Phreesia Inc

N/A

 USD1.34B 2.91 -7.97
CNVY Convey Holding Parent Inc

N/A

 USD0.77B N/A 28.37
CSLT Castlight Health Inc

N/A

 USD0.34B N/A N/A
NXU Novus Capital Corporation II

N/A

 N/A N/A N/A

ETFs Containing BBLN

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -86.88% 11% F N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -86.88% 11% F N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.32B 11% F 32% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 4.20 44% F 19% F
Price / Cash Flow Ratio -2.22 67% D+ 82% B-
EV/EBITDA -0.93 78% C+ 83% B
Management Effectiveness  
Return on Equity -711.58% 11% F 1% F
Return on Invested Capital -176.67% 11% F 2% F
Return on Assets -66.57% 11% F 0% N/A
Debt to Equity Ratio 102.01% 33% F 36% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 5.69 56% F 20% F
Short Percent 2.35% 78% C+ 62% D-
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

New Post

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.